|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|
| Cashflows from operating activities | |
| Net income (loss) | |
| Adjustments to reconcile net income (loss) to cashflows from operating activities: | |
| Depletion and depreciation | |
| Amortization of operating lease asset | |
| Asset retirement obligation accretion expense | |
| Share-based compensation | |
| Amortization of deferred financing costs | |
| Unrealized (gain) / loss on derivative instruments | |
| Deferred income tax expense (benefit) | |
| Margin returns/(calls) on derivative instruments, net | |
| Changes in operating assets and liabilities | |
| Cashflows from operating activities | |
| Cashflows used in investing activities | |
| Capital expenditures on oil and natural gas properties | |
| Cashflows from investing activities | |
| Cashflows from financing activities | |
| Issuance of shares for cash, net of issuance costs | |
| Cash acquired on acquisition | |
| Proceeds from Redeemable NCI | |
| Redemption and distributions to Redeemable NCI | |
| Proceeds from credit facility draws | |
| Repayment on credit facility | |
| Proceeds from promissory notes | |
| Repayment of promissory notes | |
| Repayment of asset backed preferred notes | |
| ABS Facility issuance, net of issuance costs | |
| Payment on ABS Facility | |
| Other long term debt repayment | |
| Dividends on common shares and noncontrolling interest | |
| Cash used for common share repurchases | |
| Cashflows provided by financing activities | |
| Net increase/(decrease) in cash and cash equivalents and restricted cash | |
| Cash, cash equivalents and restricted cash, beginning of year | |
| Cash, cash equivalents and restricted cash, end of year |
Loading...
